Correspondence regarding: diagnostic utility of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 2009:68;1319-25

J Neuropathol Exp Neurol. 2010 Mar;69(3):320; author reply 320-1. doi: 10.1097/NEN.0b013e3181d3ee9f.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / genetics
  • Cost-Benefit Analysis
  • DNA Mutational Analysis*
  • Diagnosis, Differential
  • False Negative Reactions
  • False Positive Reactions
  • Fixatives / chemistry
  • Formaldehyde / chemistry
  • Genetic Markers
  • Glioma / diagnosis*
  • Glioma / genetics
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Paraffin
  • Practice Patterns, Physicians'
  • Predictive Value of Tests
  • Time Factors
  • Tissue Embedding
  • Tissue Fixation

Substances

  • Biomarkers, Tumor
  • Fixatives
  • Genetic Markers
  • Formaldehyde
  • Paraffin
  • Isocitrate Dehydrogenase
  • IDH1 protein, human